Technology to screen embryos before implantation falls short

March 31, 2017 by David Orenstein
In in vitro fertilization a key question is whether the resulting embryo will have the proper number of chromosomes, and, if not, why not. Credit: Brown University

The healthy development of an embryo created through in vitro fertilization (IVF) depends on whether most, if not all, of the cells have the proper number of chromosomes. With pre-implantation genetic screening (PGS) technology, doctors can, in principle, spot-check chromosome count before choosing which embryo to implant in the mother. In a new article, however, scholars at Brown University and the University of Washington report that PGS has serious limitations that can only be overcome with more human embryo research, even as they acknowledge the controversy surrounding that research.

What doctors and hopeful parents want to see in PGS is 46 chromosomes—two pairs of 23—a normal state of affairs called "euploidy." An abnormal number, or "aneuploidy," could signal a fatal flaw in early development. In 2013 in the United States, more than 15 percent of IVF pregnancies ended in miscarriage, often because of aneuploidy, wrote Dr. Eli Adashi, professor of medical science and former dean of medicine and biological sciences at Brown, and Rajiv McCoy, a genome sciences postdoctoral fellow at Washington. The miscarriage rate rises quickly with maternal age, as does the rate of aneuploidy.

Hoping to prevent a bitter loss, a growing percentage of infertility patients using IVF have turned to PGS. But as Adashi and McCoy wrote in the journal EMBO Reports, PGS has yielded mixed results. Sometimes it has predicted the doom of that became healthy children, and in the small studies conducted so far, there has been mixed evidence that its use leads to a greater likelihood of a successful pregnancy.

"The impact of PGS on the outcome of assisted reproduction remains uncertain," they wrote.

Tricky biology and ideology

The problem with PGS, Adashi and McCoy wrote, stems from how little doctors and scientists really know about early embryo development, which is a complex process. There are two main sources of aneuploidy—the original cell division that creates an egg cell, called meiosis, and the division of in the growing embryo, called mitosis. The first cause, because it occurs in one of the two sex cells that form an embryo, is especially serious and is known to increase with . Errors in mitosis will affect some but rarely all the cells in an embryo.

In most applications of PGS, doctors sample genetic material from several cells on the outer edge of a five-day old embryo, called a blastocyst. If that yields evidence of aneuploidy, the test usually still can't discern whether it's meiotic, in which case all cells could be affected, or mitotic, in which only a few might be (creating a "mosaic" of ploidy).

Among the many things doctors don't know is what ploidy status they would find if they could safely look elsewhere in the embryo, including its inner cells. Finally, they don't understand yet why some mosaic embryos will succeed and others will not.

"Such insights may improve the diagnosis and selection of healthy embryos through PGS and hopefully will lead to the development of new technologies," Adashi and McCoy wrote.

But human embryo research remains controversial in many places around the world, including the U.S., they acknowledge. Public funding, and sometimes the research itself, is often prohibited.

They conclude with a call to accelerate research.

"This state of affairs hampers the acquisition of new insights into the intricate process of early human development," they wrote. "More importantly, translational breakthroughs intent on improving infertility care are being delayed. Patients afflicted with infertility deserve better."

Explore further: Solving the mystery of defective embryos

More information: Eli Y Adashi et al, Technology versus biology: the limits of pre‐implantation genetic screening, EMBO reports (2017). DOI: 10.15252/embr.201743941

Related Stories

Solving the mystery of defective embryos

January 4, 2016
It's the dream of many infertile couples: to have a baby. Tens of thousands of children are born by in vitro fertilization, or IVF, a technique commonly used when nature doesn't take its course. However, embryos obtained ...

Mitochondrial DNA levels as a marker of embryo viability in IVF

July 4, 2016
Despite the claims and counter-claims for new embryo assessment techniques introduced over the past two decades, the search for the holy grail of assisted reproduction - the key to the embryo destined to implant - continues. ...

Common gene variant linked to chromosome errors and early pregnancy loss

October 8, 2015
Researchers have identified a common genetic variant strongly associated with chromosome gains and losses during the early stages of human embryonic development. These errors in cell division, which are almost always fatal ...

Early-stage embryos with abnormalities may still develop into healthy babies, study shows

March 29, 2016
Abnormal cells in the early embryo are not necessarily a sign that a baby will be born with a birth defect such as Down's syndrome, suggests new research carried out in mice at the University of Cambridge. In a study published ...

Uterine glands vital for embryo growth, successful pregnancies

February 6, 2017
The majority of pregnancy losses occur during the first trimester, when biological communication between the embryo and mother is critical for the establishment of the pregnancy. Scientists and doctors have known for several ...

New technique takes guesswork out of IVF embryo selection

August 25, 2016
Researchers at the University of Adelaide have successfully trialed a new technique that could aid the process of choosing the "best" embryo for implantation, helping to boost the chances of pregnancy success from the very ...

Recommended for you

First time mums with an epidural who lie down more likely to have a normal birth

October 18, 2017
Adopting a lying down position rather than being upright in the later stages of labour for first-time mothers who have had a low dose epidural leads to a higher chance of them delivering their baby without any medical intervention, ...

Mice delivered by C-section gain more weight than those delivered naturally

October 11, 2017
Mice born by Caesarian section gained on average 33 percent more weight in the 15 weeks after weaning than mice born vaginally, with females gaining 70 percent more weight.

Study shows epidurals don't slow labor

October 10, 2017
Epidural analgesia - a mix of anesthetics and narcotics delivered by catheter placed close to the nerves of the spine - is the most effective method of labor pain relief. In widespread use since the 1970s, epidurals have ...

Progesterone does not prevent preterm birth or complications, says study

October 3, 2017
An increasingly popular hormonal "treatment" for pregnant women with a history of preterm birth does not work, a major new international study shows.

Study questions practice of placenta eating by new moms

September 29, 2017
(HealthDay)—You may have heard that some new mothers choose to eat their own placenta after childbirth. But there's no indication the trendy practice offers any health benefits, and some evidence it could prove dangerous, ...

Hope for couples suffering IVF miscarriage

September 20, 2017
Women who miscarry during their first full round of IVF are more likely to have a baby after further treatment than women who don't get pregnant at all.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.